|
|
|
|
|
| February 10,
2011 | ISSUE NUMBER 186 VOL 8 |
Regulatory
Lethal Injections and Foreign Inspections
The drug shortage following Hospira’s decision to stop manufacturing sodium thiopental—which is used in lethal injections—has led to a federal lawsuit that raises questions about the way the FDA controls imported drugs.
Global
Pharma Relief at UK Bribery Delay
The three-month delay to the UK’s controversial new Bribery Act could help pharma companies better prepare for its implications.
Compliance
How Packaging Promotes Patient Adherence
Many factors can contribute to the promotion of patient adherence—but packaging is one that has so far been overlooked.
Brand of the Year
Prolia: Runner-Up in Pharm Exec’s Brand of the Year Awards
Brittany Agro profiles Amgen’s osteoporosis treatment, which was named one of the Top 10 medical breakthroughs of last year, and was narrowly beaten out by Gilenya by Pharm Exec’s editors.
|
|
|
 // Allen Basis joined Advanstar Communication’s Pharma/Science Group as Publisher of BioPharm International. Allen has over 20 years’ experience in B2B publishing with K-III Directory (Primedia), LRP Publications, and SHRM Media.
// Aegerion Pharmaceuticals (Cambridge, Mass.) announced the appointment of Martha J. Carter to its executive team as Chief Regulatory Officer.
// Lissette Capati has rejoined health and science communications company Spectrum (Washington, DC) as Vice President. //
Otonomy (San Diego, CA), a developer of ear disorder treatments, announced the appointments of G. Michael Wall, Ph.D., as the Vice President of Product Development, and Cindy Berejikian as Vice President of Program Management. |
|
|
|
March 22-23: iPharma Connect — Digitally Connecting with Patients, Physicians, and Payers
Philadelphia, PA
May 5: Healthcare Businesswomen’s Association Woman of the Year
Fairfield, NJ
April 8-10: Asian Oncology Summit 2011
Hong Kong
|
|
| |
Patient Behavior Doesn't Start or End with an Rx
Learn more about the dynamics of your market, including patient and prescriber behavior, by combining information about patient activities as they travel through their Continuum of CareTM. Monitor patients as they fill prescriptions, visit their physician, receive lab test results, go to the hospital, and make retail purchases.
 Click here to find out what you're missing. |
| |
CBI’s 10thiPharmaConnect—3/21-22, Philadelphia, PA
Don’t miss the digital event of the year! Hear from the best minds in eMarketing onthe hottest industry topics including mobile, digital, social mediaand multi-channel integration. Hear directly from your customers and participate in interactive sessions and debates. Plus! DDMAC presents an update on internet and social media! Registerat
 www.cbinet.com/ipharmaconnect and save $400 with code NRN887. |
|
|
|
|
 |
|
 |
|
 |
| What should pharma’s relationship with patients be? |
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
